Hien Dang, Atsushi Takai, Marshonna Forgues, Yotsowat Pomyen, Haiwei Mou, Wen Xue, Debashish Ray, Kevin C.H. Ha, Quaid D. Morris, Timothy R. Hughes, Xin Wei Wang
文献索引:10.1016/j.ccell.2017.06.002
全文:HTML全文
Global transcriptomic imbalance is a ubiquitous feature associated with cancer, including hepatocellular carcinoma (HCC). Analyses of 1,225 clinical HCC samples revealed that a large numbers of RNA binding proteins (RBPs) are dysregulated and that RBP dysregulation is associated with poor prognosis. We further identified that oncogenic activation of a top candidate RBP, negative elongation factor E (NELFE), via somatic copy-number alterations enhanced MYC signaling and promoted HCC progression. Interestingly, NELFE induces a unique tumor transcriptome by selectively regulating MYC-associated genes. Thus, our results revealed NELFE as an oncogenic protein that may contribute to transcriptome imbalance in HCC through the regulation of MYC signaling.
HDAC Inhibitors Finally Open Up: Chromatin Accessibility Sig...
2017-07-10 [10.1016/j.ccell.2017.06.008] |
Redefining Hormonal Therapy for Advanced Prostate Cancer: Re...
2017-07-10 [10.1016/j.ccell.2017.06.007] |
MUC-king with HIF May Rewire Pyrimidine Biosynthesis and Cur...
2017-07-10 [10.1016/j.ccell.2017.06.006] |
Choose and Use Your Chemical Probe Wisely to Explore Cancer ...
2017-07-10 [10.1016/j.ccell.2017.06.005] |
MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glu...
2017-07-10 [10.1016/j.ccell.2017.06.004] |
首页 |
期刊大全 |
MSDS查询 |
化工产品分类 |
生物活性化合物 |
关于我们 |
免责声明:知识产权问题请联系 service1@chemsrc.com
Copyright © 2024 ChemSrc All Rights Reserved